doi: 10.1128/AAC.35.6.1219.
Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria
Affiliations
- PMID: 1929265
- PMCID: PMC284314
- DOI: 10.1128/AAC.35.6.1219
Item in Clipboard
Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria
Antimicrob Agents Chemother.
1991 Jun.
Abstract
The in vitro activities of several new beta-lactam-beta-lactamase inhibitor combinations (piperacillin plus tazobactam, ceftizoxime and cefonicid with sulbactam and clavulanic acid, and ampicillin plus 8 micrograms of sulbactam per ml) were tested with anaerobic bacteria and compared with known beta-lactam-beta-lactamase inhibitor combinations and other potent antianaerobe agents. All the combinations tested (except for the cefonicid-inhibitor combinations) were active against almost all strains of the Bacteroides fragilis group. This report indicates that beta-lactamase inhibitors may improve the activity of beta-lactam agents with marginal activity against the B. fragilis group.
Similar articles
-
Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes.Antimicrob Agents Chemother. 1986 Nov;30(5):789-91. doi: 10.1128/AAC.30.5.789. Antimicrob Agents Chemother. 1986. PMID: 3026241 Free PMC article.
-
Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.Diagn Microbiol Infect Dis. 1992 May-Jun;15(4):321-30. doi: 10.1016/0732-8893(92)90018-o. Diagn Microbiol Infect Dis. 1992. PMID: 1611847
-
Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.Braz J Infect Dis. 2000 Feb;4(1):22-8. Braz J Infect Dis. 2000. PMID: 10788842
-
Susceptibility of anaerobic bacteria to beta-lactam antibiotics in the United States.Clin Infect Dis. 1993 Jun;16 Suppl 4:S371-6. doi: 10.1093/clinids/16.supplement_4.s371. Clin Infect Dis. 1993. PMID: 8324150 Review.
-
Comparative susceptibility profile of piperacillin/tazobactam against anaerobic bacteria.J Antimicrob Chemother. 1993 Jan;31 Suppl A:29-38. doi: 10.1093/jac/31.suppl_a.29. J Antimicrob Chemother. 1993. PMID: 8383654 Review.
Cited by
-
Current antimicrobial therapy of anaerobic infections.Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):999-1011. doi: 10.1007/BF01967790. Eur J Clin Microbiol Infect Dis. 1992. PMID: 1295770 Review.
-
Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin.Antimicrob Agents Chemother. 1992 May;36(5):1140-3. doi: 10.1128/AAC.36.5.1140. Antimicrob Agents Chemother. 1992. PMID: 1324639 Free PMC article.
-
Survey of Bacteroides fragilis group susceptibility patterns in Canada.Antimicrob Agents Chemother. 1992 Feb;36(2):343-7. doi: 10.1128/AAC.36.2.343. Antimicrob Agents Chemother. 1992. PMID: 1605600 Free PMC article.
-
Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.Drugs. 1994 Mar;47(3):506-35. doi: 10.2165/00003495-199447030-00008. Drugs. 1994. PMID: 7514977 Review.
-
In vitro activity of ceftriaxone combined with tazobactam against anaerobic bacteria.Eur J Clin Microbiol Infect Dis. 1994 Feb;13(2):177-81. doi: 10.1007/BF01982195. Eur J Clin Microbiol Infect Dis. 1994. PMID: 8013494
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
